<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Latest Medical Technology from Bio-Medicine.Org</title>
<link>http://www.bio-medicine.org/medicine-technology-1/</link>
<description>Latest Medical Technology lists</description>
<language>en-us</language>
<copyright>Copyright 2007. Bio-Medicine All Rights Reserved.</copyright>
<item>
<title><![CDATA[Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Landauer--Inc--Sets-Date-and-Time-for-Announcement-of-Fiscal-Fourth-Quarter-and-Full-Year-2009-Results-6442-1/</link>
<pubDate>Fri, 20 Nov 2009 01:07:51 MST</pubDate>
<description><![CDATA[GLENWOOD, Ill., Nov. 20 /PRNewswire-FirstCall/  --   Landauer, Inc.  ( LDR) ,  will release financial results for the fiscal fourth quarter and full year of 2009 pre-market on Tuesday, December 1, 2009.       The company will host a conference call for investors on Tuesday, December 1, 2009, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-9205 (within... ]]></description>
</item>
<item>
<title><![CDATA[Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Medco-Reforming-Healthcare-with-Smarter-Medicine-3B-Wired--Transformational-Pharmacy-Model-Advances-Clinical-Quality-and-Lowers-Cost-6441-1/</link>
<pubDate>Fri, 20 Nov 2009 01:07:34 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /- Medco Health Solutions, Inc (NYSE:   MHS ) is today contributing to a transformation in American healthcare through an advanced, wired pharmacy paradigm that is already delivering higher quality clinical care and fundamentally bending the cost curve downward -- making medicine smarter for the benefit of patients and payors alike.       The... ]]></description>
</item>
<item>
<title><![CDATA[Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Pennsylvania-Department-of-Health-Begins-Statewide-H1N1-Vaccination-Clinics-Targeting-Priority-Populations-3B-Some-Appointments-Still-Available-6440-1/</link>
<pubDate>Fri, 20 Nov 2009 01:07:28 MST</pubDate>
<description><![CDATA[HARRISBURG, Pa., Nov. 20 /PRNewswire-USNewswire/ -- The Department of Health today began providing free H1N1 flu shots to members of priority groups that did not have previous access to the vaccine.       A total of 18 clinics are being held statewide on Nov. 20-22. Friday's clinic hours are from 2 p.m. to 8 p.m. Hours on Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On Sunday, Nov. 2... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds Blood Pressure Monitoring &amp; Measurement Instruments - A World Market Analysis]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Reportlinker-Adds-Blood-Pressure-Monitoring--26amp-3B-Measurement-Instruments---A-World-Market-Analysis-6439-1/</link>
<pubDate>Fri, 20 Nov 2009 10:12:21 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /- Reportlinker.com announces that a new market research report is available in its catalogue.        Blood Pressure Monitoring &amp; Measurement Instruments - A World Market Analysis          http://www.reportlinker.com/p0164309/Blood-Pressure-Monitoring--Measurement-Instruments---A-World-Market-Analysis.html#utm_source=prnewswire&amp;utm_medium=pr... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Reportlinker-Adds-Global-Self-Monitoring-Blood-Glucose-Market--28SMBG-29-3A-Increasing-Adoption-to-Drive-Growth-6438-1/</link>
<pubDate>Fri, 20 Nov 2009 10:12:12 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /- Reportlinker.com announces that a new market research report is available in its catalogue.        Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth          http://www.reportlinker.com/p0164657/Global-Self-Monitoring-Blood-Glucose-Market-(SMBG )-Increasing-Adoption-to-Drive-Growth.html#utm_source=prnewswire&... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds Pipettes &amp; Pipettors - A Global Market Perspective]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Reportlinker-Adds-Pipettes--26amp-3B-Pipettors---A-Global-Market-Perspective-6437-1/</link>
<pubDate>Fri, 20 Nov 2009 10:12:06 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /- Reportlinker.com announces that a new market research report is available in its catalogue.        Pipettes &amp; Pipettors - A Global Market Perspective          http://www.reportlinker.com/p0164373/Pipettes--Pipettors---A-Global-Market-Perspective.html#utm_source=prnewswire&amp;utm_medium=pr&amp;utm_campaign=prnewswire         Pipettes and pipe... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Reportlinker-Adds-India-Medical-Equipment-Market-Analysis-and-Forecasts-to-2015-6436-1/</link>
<pubDate>Fri, 20 Nov 2009 10:11:58 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /-        Reportlinker.com announces that a new market research report is available in its catalogue.        India Medical Equipment Market Analysis and Forecasts to 2015          http://www.reportlinker.com/p0164658/India-Medical-Equipment-Market-Analysis-and-Forecasts-to-2015.html#utm_source=prnewswire&amp;utm_medium=pr&amp;utm_campaign=prnewswire... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds Global Markets for Breast Biopsy Devices 2009]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Reportlinker-Adds-Global-Markets-for-Breast-Biopsy-Devices-2009-6435-1/</link>
<pubDate>Fri, 20 Nov 2009 10:11:51 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /-       Reportlinker.com announces that a new market research report is available in its catalogue.        Global Markets for Breast Biopsy Devices 2009          http://www.reportlinker.com/p0164741/Global-Markets-for-Breast-Biopsy-Devices-2009.html#utm_source=prnewswire&amp;utm_medium=pr&amp;utm_campaign=prnewswire         The global markets for b... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Reportlinker-Adds-Global-Markets-for-Assisted-Reproductive-Devices-2009-6434-1/</link>
<pubDate>Fri, 20 Nov 2009 10:11:47 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /- Reportlinker.com announces that a new market research report is available in its catalogue.        Global Markets for Assisted Reproductive Devices 2009          http://www.reportlinker.com/p0164742/Global-Markets-for-Assisted-Reproductive-Devices-2009.html#utm_source=prnewswire&amp;utm_medium=pr&amp;utm_campaign=prnewswire         Global Markets... ]]></description>
</item>
<item>
<title><![CDATA[Reportlinker Adds Medical Adhesives and Sealants - A US Market Review]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Reportlinker-Adds-Medical-Adhesives-and-Sealants---A-US-Market-Review-6433-1/</link>
<pubDate>Fri, 20 Nov 2009 10:11:42 MST</pubDate>
<description><![CDATA[NEW YORK, Nov. 20 /- Reportlinker.com announces that a new market research report is available in its catalogue.        Medical Adhesives and Sealants - A US Market Review          http://www.reportlinker.com/p0164242/Medical-Adhesives-and-Sealants---A-US-Market-Review.html#utm_source=prnewswire&amp;utm_medium=pr&amp;utm_campaign=prnewswire         The use of medical... ]]></description>
</item>
<item>
<title><![CDATA[Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Boston-Scientific-Announces-FDA-Clearance-and-CE-Mark-for-WallFlex-28R-29-Fully-Covered-Esophageal-Stent-6432-1/</link>
<pubDate>Fri, 20 Nov 2009 08:52:16 MST</pubDate>
<description><![CDATA[NATICK, Mass. and LONDON, Nov. 20 /- Boston Scientific Corporation (NYSE:   BSX ) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex&#174; Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients... ]]></description>
</item>
<item>
<title><![CDATA[Biotel Announced Profitable First Quarter Ended September 30, 2009]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Biotel-Announced-Profitable-First-Quarter-Ended-September-30--2009-6431-1/</link>
<pubDate>Fri, 20 Nov 2009 08:52:10 MST</pubDate>
<description><![CDATA[MINNEAPOLIS, Nov. 20 /- Biotel Inc. (OTC Bulletin Board: BTEL) announced results for its first quarter ended September 30, 2009 with net earnings of $128,000, or $0.04 per diluted share, on revenues of $3,263,000.  This compares to net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000 for the first quarter of last year.       Commenting... ]]></description>
</item>
<item>
<title><![CDATA[Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Cyberonics-to-Present-at-21st-Annual-Piper-Jaffray-Health-Care-Conference-6430-1/</link>
<pubDate>Fri, 20 Nov 2009 08:51:48 MST</pubDate>
<description><![CDATA[HOUSTON, Nov. 20 /- Cyberonics, Inc. (Nasdaq:  CYBX ) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the 21st Annual Piper Jaffray Health Care Conference in New York on Wednesday, December 2, 2009 at 12:00 PM EST.  The conference session and webcast will be audio only and no for... ]]></description>
</item>
<item>
<title><![CDATA[ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/ECRI-Institute-Releases-Roadmap-to-the-Evidence-on-Finasteride-for-Prevention-of-Prostate-Cancer-3A-New-Hotline-Report-to-Aid-Healthcare-Decision-Make-6429-1/</link>
<pubDate>Fri, 20 Nov 2009 08:51:44 MST</pubDate>
<description><![CDATA[PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire-USNewswire/ -- In response to a recent  New York Times  article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on  Finasteride for Prevention of Prostate Cancer  for  free download .... ]]></description>
</item>
<item>
<title><![CDATA[BD Completes Acquisition of HandyLab, Inc.]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/BD-Completes-Acquisition-of-HandyLab--Inc--6428-1/</link>
<pubDate>Fri, 20 Nov 2009 06:04:12 MST</pubDate>
<description><![CDATA[FRANKLIN LAKES, N.J., Nov. 20 /- BD (Becton, Dickinson and Company) (NYSE:   BDX ) today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.       In May 2009, BD and HandyLab announced an exclusive agreement for BD to develop and... ]]></description>
</item>
<item>
<title><![CDATA[Smith &amp; Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Smith--26amp-3B-Nephew-Orthopaedics-Selected-to-Develop-New-Technology-for-Treating-Battlefield-Injuries-6427-1/</link>
<pubDate>Fri, 20 Nov 2009 06:04:05 MST</pubDate>
<description><![CDATA[MEMPHIS, Tenn.,   Nov. 20 /- Smith &amp; Nephew ( SNN, LSE: SN) Orthopaedics Division is pleased to announce the signing of a technology development contract with the United States Department of Defense that may lead to the creation of a fracture fixation system intended to revolutionize the treatment of the limbs of soldiers who sustain battlefield injuries.... ]]></description>
</item>
<item>
<title><![CDATA[Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Soligenix-Forms-Consortium-to-Develop-Thermostable-Technology-to-Advance-RiVax-28TM-29-and-Other-Rapidly-Acting-Vaccines-6426-1/</link>
<pubDate>Fri, 20 Nov 2009 06:03:33 MST</pubDate>
<description><![CDATA[PRINCETON, N.J., Nov. 20 /- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the... ]]></description>
</item>
<item>
<title><![CDATA[Warner Chilcott Prices Secondary Equity Offering]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/Warner-Chilcott-Prices-Secondary-Equity-Offering-6425-1/</link>
<pubDate>Thu, 19 Nov 2009 07:49:39 MST</pubDate>
<description><![CDATA[ARDEE, Ireland, Nov. 19 /- Warner Chilcott plc (Nasdaq:  WCRX ) today announced the pricing of its previously announced secondary offering of 20,000,000 of its ordinary shares at a price to the public of $22.25 per share.  The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and... ]]></description>
</item>
<item>
<title><![CDATA[BioCryst Announces Pricing of Public Offering of Common Stock]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/BioCryst-Announces-Pricing-of-Public-Offering-of-Common-Stock-6424-1/</link>
<pubDate>Thu, 19 Nov 2009 07:49:34 MST</pubDate>
<description><![CDATA[BIRMINGHAM, Ala., Nov. 19 /- BioCryst Pharmaceuticals, Inc. (Nasdaq:  BCRX ) today announced the pricing of a public offering of 5,000,000 shares of its common stock at $9.75 per share, resulting in gross proceeds of $48.75 million.  All of the shares are being offered by BioCryst pursuant to an effective shelf registration statement previously filed with the... ]]></description>
</item>
<item>
<title><![CDATA[International Operation Combats Online Supply of Counterfeit and Illegal Medicines]]></title>
<link>http://www.bio-medicine.org/medicine-technology-1/International-Operation-Combats-Online-Supply-of-Counterfeit-and-Illegal-Medicines-6423-1/</link>
<pubDate>Thu, 19 Nov 2009 07:49:28 MST</pubDate>
<description><![CDATA[LYON, France, Nov. 19 /- In response to an ever-increasing number of websites supplying dangerous and illegal medicines, Operation Pangea II, involving 24 countries, was coordinated by INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT) to highlight the dangers of buying medicines online.       The week long g... ]]></description>
</item>
</channel>
</rss>